Treatment of acute myeloid leukemia (AML) with venetoclax failure Grant US-11793802-B2 United States of America 24 Oct 2023
Treatment regimen for cancers that are insensitive to BCL-2 inhibitors using the MCL-1… Grant US-11497756-B2 United States of America 15 Nov 2022
Alvocidib prodrugs and their use as protein kinase inhibitors Grant US-11279694-B2 United States of America 22 Mar 2022
CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer Grant US-11034710-B2 United States of America 15 Jun 2021